MENU
+Compare
SIGY
Stock ticker: OTC
AS OF
Jun 6 closing price
Price
$2.75
Change
+$0.26 (+10.44%)
Capitalization
4.41M

SIGY Sigyn Therapeutics Inc. Forecast, Technical & Fundamental Analysis

Sigyn Therapeutics Inc is a development-stage therapeutic technology company... Show more

SIGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SIGY with price predictions
Jun 27, 2025

SIGY's Indicator enters downward trend

The Aroon Indicator for SIGY entered a downward trend on May 30, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 145 similar instances where the Aroon Indicator formed such a pattern. In of the 145 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SIGY's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on June 11, 2025. You may want to consider a long position or call options on SIGY as a result. In of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SIGY just turned positive on June 11, 2025. Looking at past instances where SIGY's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SIGY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). SIGY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.247).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIGY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SIGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2468 Historic Decatur Road
Phone
+1 619 353-0800
Employees
5
Web
https://www.sigyntherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOBX0.760.02
+2.42%
Mobix Labs
UNTY47.450.66
+1.41%
Unity Bancorp
SBH9.010.05
+0.56%
Sally Beauty Holdings
SPGI517.712.69
+0.52%
S&P Global
REYN21.300.03
+0.14%
Reynolds Consumer Products

SIGY and Stocks

Correlation & Price change

A.I.dvisor tells us that SIGY and ELVAF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGY and ELVAF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGY
1D Price
Change %
SIGY100%
N/A
ELVAF - SIGY
31%
Poorly correlated
N/A
IVVD - SIGY
20%
Poorly correlated
N/A
CLYYF - SIGY
12%
Poorly correlated
N/A
NBTX - SIGY
11%
Poorly correlated
-4.31%
CPMV - SIGY
6%
Poorly correlated
+37.08%
More